Publications
& Presentations

Data from this study suggest that APEX outperforms a commercial Alzheimer’s disease blood test, with better correlation to amyloid PET as compared to the ELISA test.

Data from this landmark study show that the APEX test has a 90% correlation to gold-standard PET, while all other blood-based diagnostic tests have a correlation of about 20%.

In this pilot biomarker study, the Glympse platform accurately differentiated hepatocellular carcinoma (HCC) from cirrhosis.

This study of two diverse cohorts of patients with known HCC vs. healthy controls showed that the Glympse platform was highly effective at detecting HCC.